ATE425770T1 - Kontrastmittel - Google Patents

Kontrastmittel

Info

Publication number
ATE425770T1
ATE425770T1 AT04701136T AT04701136T ATE425770T1 AT E425770 T1 ATE425770 T1 AT E425770T1 AT 04701136 T AT04701136 T AT 04701136T AT 04701136 T AT04701136 T AT 04701136T AT E425770 T1 ATE425770 T1 AT E425770T1
Authority
AT
Austria
Prior art keywords
contrast agents
formula
moiety
angiotensin
affinity
Prior art date
Application number
AT04701136T
Other languages
English (en)
Inventor
Magne Solbakken
Torgrim Engell
Harry John Wadsworth
Colin M Archer
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Application granted granted Critical
Publication of ATE425770T1 publication Critical patent/ATE425770T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0819Tripeptides with the first amino acid being acidic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0002General or multifunctional contrast agents, e.g. chelated agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0497Organic compounds conjugates with a carrier being an organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Steroid Compounds (AREA)
  • Light Receiving Elements (AREA)
AT04701136T 2003-01-09 2004-01-09 Kontrastmittel ATE425770T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20030115A NO20030115D0 (no) 2003-01-09 2003-01-09 Kontrastmiddel

Publications (1)

Publication Number Publication Date
ATE425770T1 true ATE425770T1 (de) 2009-04-15

Family

ID=19914362

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04701136T ATE425770T1 (de) 2003-01-09 2004-01-09 Kontrastmittel

Country Status (8)

Country Link
US (1) US7919071B2 (de)
EP (1) EP1581262B1 (de)
JP (1) JP2006517539A (de)
CN (1) CN1723043A (de)
AT (1) ATE425770T1 (de)
DE (1) DE602004020049D1 (de)
NO (1) NO20030115D0 (de)
WO (1) WO2004062568A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20034350D0 (no) * 2003-09-29 2003-09-29 Amersham Health As Optisk avbilding av kolorektal kreft
US7431914B2 (en) 2003-11-24 2008-10-07 Ge Healthcare As Contrast agent
US7763234B2 (en) 2004-03-04 2010-07-27 Ge Healthcare As Pharmaceutical compounds
FR2902428B1 (fr) * 2006-06-15 2008-08-15 Servier Lab Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2008058551A1 (en) * 2006-11-13 2008-05-22 Telefonaktiebolaget L M Ericsson (Publ) Wireless telecommunications systems
JP2010512310A (ja) * 2006-12-11 2010-04-22 ジーイー・ヘルスケア・アクスイェ・セルスカプ 放射性標識ペプチド系化合物及びその使用
TW201215388A (en) * 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
GB201103696D0 (en) 2011-03-04 2011-04-20 Ge Healthcare Ltd Technetium labelled peptides
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
GB201322456D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
WO2019134765A1 (en) 2018-01-08 2019-07-11 Julius-Maximilians-Universitaet Wuerzburg Sartan analogue

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0365378A (ja) * 1989-08-04 1991-03-20 Tokyo Tatsuno Co Ltd 複写伝票
US5808091A (en) * 1991-10-29 1998-09-15 Bracco International B.V. Rhenium and technetium complexes containing a hypoxia localizing moiety
JPH09165378A (ja) 1995-12-15 1997-06-24 Seitai Kinou Kenkyusho:Kk N1−[18f]フルオロベンジル複素環化合物およびそれらの製造法
EP0971747B1 (de) * 1996-10-28 2005-12-28 Amersham Health AS Kontrastmittel
KR100866666B1 (ko) * 2000-04-12 2008-11-04 지이 헬스케어 에이에스 펩티드 기재 화합물
AU6972901A (en) 2000-05-31 2001-12-11 Mayo Foundation Cobalamin compounds useful as cardiovascular agents and as imaging agents
GB0031592D0 (en) * 2000-12-28 2001-02-07 Nycomed Amersham Plc Stabilised radiopharmaceutical compositions
GB0105224D0 (en) 2001-03-02 2001-04-18 Nycomed Amersham Plc Improved peptide-chelate conjugates
HU230901B1 (hu) * 2001-07-10 2019-01-28 Ge Healthcare Limited Peptidalapú vegyületek és ezeket tartalmazó gyógyszerkészítmények
GB0116815D0 (en) * 2001-07-10 2001-08-29 Nycomed Amersham Plc Improved chelator conjugates

Also Published As

Publication number Publication date
JP2006517539A (ja) 2006-07-27
EP1581262A2 (de) 2005-10-05
EP1581262B1 (de) 2009-03-18
WO2004062568A2 (en) 2004-07-29
CN1723043A (zh) 2006-01-18
US20070020176A1 (en) 2007-01-25
WO2004062568A3 (en) 2004-09-30
US7919071B2 (en) 2011-04-05
DE602004020049D1 (de) 2009-04-30
NO20030115D0 (no) 2003-01-09

Similar Documents

Publication Publication Date Title
MXPA04000173A (es) Compuestos basados en peptidos.
NO20073039L (no) Kontrastmidler
DE602004020049D1 (de) Kontrastmittel
DK1272507T3 (da) Integrinbindende peptidderivater
SG149895A1 (en) Contrast agents for myocardial perfusion imaging
ATE439868T1 (de) Targetingmittel für molekulare bilderzeugung
ATE314097T1 (de) Kontrastmittel
IL173029A0 (en) Imaging agents
BR0308090A (pt) conjugados de agentes citotóxicos ou terapêuticos e peptìdios biologicamente ativos
WO1998018497A3 (en) Contrast agents
DE602005024279D1 (de) 5-substituierte-2-phenylaminobenzamide als mek-inhibitoren
ATE349446T1 (de) Amyloid plaque aggregationshemmer und diagnostische bilderzeugungsmittel
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
TR200101673A2 (tr) Düz kas hücrelerinin sıkışmasıyla ilgili hastalıkların tedavisindeki kompozisyonlar için biyokimyasal maddeler.
GB0326546D0 (en) Inhibitor imaging agents
EP1641423A4 (de) Benzodiazepin-cgrp-rezeptor-antagonisten
ATE376428T1 (de) Metallkomplexverbindungen
EP1758605A4 (de) Prouroguanylin als therapeutische und diagnostische mittel
DK1021534T3 (da) Hepatitis C-receptorprotein CD81
ATE310736T1 (de) Verbindungen zur bilddarstellung der alzheimer- krankenheit
WO2007020341A3 (fr) Systeme imageur d'un organe humain ou animal permettant la mesure de l'elasticite dudit organe
ATE480552T1 (de) Stq-peptide
WO2005049095A3 (en) Contrast agent imaging angiotensin ii receptors
CY1106950T1 (el) Μονοενυδρο αλας νατριου της s-tενατοπραζολης και εφαρμογη υπο τυπον αναστολεα αντλιας πρωτονιων
WO2007064661A3 (en) Bifunctional metal chelating conjugates

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties